XML 77 R60.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Acquisitions of Businesses, 2024 Acquisitions (Details) $ in Thousands |  |  |  |  |  |  |  |  |  |  |  |  |  | 12 Months Ended |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Nov. 30, 2024 USD ($) Clinic | Oct. 31, 2024 USD ($) shares | Aug. 31, 2024 USD ($) Clinic | Apr. 30, 2024 USD ($) | Mar. 29, 2024 USD ($) Clinic | Jul. 31, 2023 USD ($) Clinic | May 31, 2023 USD ($) Clinic | Feb. 28, 2023 USD ($) Clinic | Nov. 30, 2022 USD ($) Clinic | Oct. 31, 2022 USD ($) Clinic | Sep. 30, 2022 USD ($) Clinic | Aug. 31, 2022 USD ($) Clinic | Mar. 31, 2022 USD ($) Clinic | Dec. 31, 2024 USD ($) | Dec. 31, 2023 USD ($) | Dec. 31, 2022 USD ($) | Oct. 31, 2023
Business Combination, Description [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Contingent payments |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 17,600 | $ 9,800 |  |
Cash paid, net of cash acquired |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 133,087 | $ 26,582 | $ 59,788 |
Customer and Referral Relationships [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Estimated fair value of net tangible assets acquired [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Estimated useful lives of acquired intangibles |  |  |  |  |  |  |  |  |  |  |  |  |  | 12 years |  | 12 years 2 months 12 days |
Non-compete Agreements [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Estimated fair value of net tangible assets acquired [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Estimated useful lives of acquired intangibles |  |  |  |  |  |  |  |  |  |  |  |  |  | 5 years |  | 5 years |
Clinic Practice [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Description [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of interest acquired | 75.00% |  | 70.00% |  | 50.00% | 70.00% | 75.00% | 80.00% | 80.00% | 60.00% | 80.00% | 70.00% | 70.00% |  |  |  |
Number of clinics | Clinic | 8 |  | 8 |  | 9 | 5 | 4 | 1 | 13 | 14 | 2 | 6 | 6 |  |  |  |
Percentage of interest retained by practice founder | 25.00% |  | 30.00% |  | 50.00% | 30.00% |  | 20.00% | 20.00% | 40.00% | 20.00% | 30.00% | 30.00% |  |  |  |
Aggregate purchase price for acquisition | $ 15,900 |  | $ 2,000 |  | $ 16,400 | $ 2,100 | $ 3,100 | $ 6,200 | $ 25,000 | $ 19,500 | $ 4,200 | $ 3,500 | $ 11,500 |  |  |  |
Cash paid for acquisition | 15,700 |  |  |  | $ 500 |  |  |  | 24,200 |  | 3,900 | 3,300 | 11,200 |  |  |  |
Seller note | $ 200 |  |  |  |  |  | 300 | $ 400 | $ 800 |  | $ 300 | $ 200 | $ 300 |  |  |  |
Percentage of interest accrued | 5.00% |  |  |  | 4.50% |  |  | 4.50% | 7.00% |  | 5.50% | 5.50% | 3.50% |  |  |  |
Contingent payments |  |  |  |  |  |  |  |  |  | $ 9,700 |  |  |  | $ 3,200 |  |  |
Cash paid, net of cash acquired |  |  |  |  |  | $ 1,800 | $ 1,700 | $ 5,800 |  |  |  |  |  |  |  |  |
Clinic Practice [Member] | Maximum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Description [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of interest acquired |  |  |  |  |  |  |  |  |  |  |  |  |  | 35.00% | 35.00% | 35.00% |
Contingent payments |  |  | $ 3,600 |  |  |  |  |  | $ 1,600 |  |  |  |  | $ 200 |  |  |
MSO Metro LLC [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Description [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of interest acquired |  | 50.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate purchase price for acquisition |  | $ 76,500 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash paid for acquisition |  | 75,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares issued |  | $ 1,500 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares issued (in shares) | shares |  | 18,358 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock average trailing period |  | 5 days |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Contingent payments |  | $ 20,000 |  |  |  |  |  |  |  |  |  |  |  | 11,300 |  |  |
MSO Metro LLC [Member] | Maximum [Member] | Director and Other Owners [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Description [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Right to require percentage of voting interests |  | 20.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IIP Business [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Description [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of interest acquired |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 100.00%
Seller note |  |  |  |  |  |  |  |  |  |  |  |  |  | 455 | $ 0 |  |
Shares issued |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |  |  |
Contingent payments |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,100 | 0 |  |
Cash paid, net of cash acquired |  |  |  |  |  |  |  |  |  |  |  |  |  | 23,106 | 3,955 |  |
Estimated fair value of net tangible assets acquired [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total current assets |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,211 | 392 |  |
Total non-current assets |  |  |  |  |  |  |  |  |  |  |  |  |  | 218 | 335 |  |
Total liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  | (541) | (41) |  |
Net tangible assets acquired |  |  |  |  |  |  |  |  |  |  |  |  |  | 888 | 686 |  |
Customer and referral relationships |  |  |  |  |  |  |  |  |  |  |  |  |  | 6,708 | 757 |  |
Non-compete agreements |  |  |  |  |  |  |  |  |  |  |  |  |  | 261 | 37 |  |
Tradenames |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,331 | 187 |  |
Goodwill |  |  |  |  |  |  |  |  |  |  |  |  |  | 16,473 | 2,562 |  |
Fair value of non-controlling interest (classified as redeemable non-controlling interest) |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | (274) |  |
Total consideration |  |  |  |  |  |  |  |  |  |  |  |  |  | 25,661 | 3,955 |  |
IIP Business [Member] | Briotix Health, Limited Partnership [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Description [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of interest acquired |  |  |  | 100.00% |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate purchase price for acquisition |  |  |  | $ 24,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Cash paid for acquisition |  |  |  | $ 500 |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of interest accrued |  |  |  | 5.00% |  |  |  |  |  |  |  |  |  |  |  |  |
Contingent payments |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,500 |  |  |
IIP Business [Member] | Briotix Health, Limited Partnership [Member] | Maximum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Description [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Contingent payments |  |  |  | $ 10,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Acquisitions [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Description [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash paid for acquisition |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 59,788 |
Seller note |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,675 | 985 | 1,574 |
Shares issued |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,500 |  |  |
Contingent payments |  |  |  |  |  |  |  |  |  |  |  |  |  | 17,671 | 200 | 10,000 |
Cash paid, net of cash acquired |  |  |  |  |  |  |  |  |  |  |  |  |  | 133,087 | 26,582 |  |
Estimated fair value of net tangible assets acquired [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total current assets |  |  |  |  |  |  |  |  |  |  |  |  |  | 10,902 | 1,533 | 1,329 |
Total non-current assets |  |  |  |  |  |  |  |  |  |  |  |  |  | 31,327 | 3,484 | 7,798 |
Total liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  | (29,043) | (3,204) | (10,930) |
Net tangible assets acquired |  |  |  |  |  |  |  |  |  |  |  |  |  | 13,186 | 1,813 | (1,803) |
Customer and referral relationships |  |  |  |  |  |  |  |  |  |  |  |  |  | 60,726 | 7,576 | 18,062 |
Non-compete agreements |  |  |  |  |  |  |  |  |  |  |  |  |  | 3,554 | 366 | 934 |
Tradenames |  |  |  |  |  |  |  |  |  |  |  |  |  | 13,641 | 1,867 | 5,445 |
Goodwill |  |  |  |  |  |  |  |  |  |  |  |  |  | 164,529 | 28,083 | 75,525 |
Fair value of non-controlling interest (classified as redeemable non-controlling interest) |  |  |  |  |  |  |  |  |  |  |  |  |  | (101,703) | (11,108) | (26,801) |
Total consideration |  |  |  |  |  |  |  |  |  |  |  |  |  | 153,933 | 28,597 | $ 71,362 |
Acquisitions [Member] | Physical Therapy Operations [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Description [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Seller note |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,220 | 985 |  |
Shares issued |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,500 |  |  |
Contingent payments |  |  |  |  |  |  |  |  |  |  |  |  |  | 15,571 | 200 |  |
Cash paid, net of cash acquired |  |  |  |  |  |  |  |  |  |  |  |  |  | 109,981 | 22,627 |  |
Estimated fair value of net tangible assets acquired [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total current assets |  |  |  |  |  |  |  |  |  |  |  |  |  | 9,691 | 1,141 |  |
Total non-current assets |  |  |  |  |  |  |  |  |  |  |  |  |  | 31,109 | 3,149 |  |
Total liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  | (28,502) | (3,163) |  |
Net tangible assets acquired |  |  |  |  |  |  |  |  |  |  |  |  |  | 12,298 | 1,127 |  |
Customer and referral relationships |  |  |  |  |  |  |  |  |  |  |  |  |  | 54,018 | 6,819 |  |
Non-compete agreements |  |  |  |  |  |  |  |  |  |  |  |  |  | 3,293 | 329 |  |
Tradenames |  |  |  |  |  |  |  |  |  |  |  |  |  | 12,310 | 1,680 |  |
Goodwill |  |  |  |  |  |  |  |  |  |  |  |  |  | 148,056 | 25,521 |  |
Fair value of non-controlling interest (classified as redeemable non-controlling interest) |  |  |  |  |  |  |  |  |  |  |  |  |  | (101,703) | (10,834) |  |
Total consideration |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 128,272 | $ 24,642 |  |

X
- Definition Number of shares of equity interests issued or issuable to acquire entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 805 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(4) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1 + Details
Name: | us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of voting equity interests acquired at the acquisition date in the business combination. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2 + Details
Name: | us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1 + Details
Name: | us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 30 -Paragraph 8 -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b) -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 30 -Paragraph 7 -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7 + Details
Name: | us-gaap_BusinessCombinationConsiderationTransferred1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 30 -Paragraph 8 -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 30 -Paragraph 7 -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7 + Details
Name: | us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of liability recognized arising from contingent consideration in a business combination. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 805 -SubTopic 30 -Name Accounting Standards Codification -Section 35 -Paragraph 1 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479613/805-30-35-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 25 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479668/805-30-25-6 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- References No definition available. + Details
Name: | us-gaap_BusinessCombinationDescriptionAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 55 -Paragraph 37 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Contractual interest rate for funds borrowed, under the debt agreement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(22)(a)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B + Details
Name: | us-gaap_DebtInstrumentInterestRateStatedPercentage
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of businesses acquired by the entity during the period. + References No definition available. + Details
Name: | us-gaap_NumberOfBusinessesAcquired
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13 + Details
Name: | us-gaap_PaymentsToAcquireBusinessesGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13 + Details
Name: | us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Average days of common stock trailing period during business acquisition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | usph_BusinessAcquisitionAverageDaysOfCommonStockTrailingPeriod
Namespace Prefix: | usph_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of business acquisition cost of acquired entity debt issued on the date of acquisition. + References No definition available. + Details
Name: | usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued
Namespace Prefix: | usph_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Percentage of voting equity interests retained by practice founder at the acquisition date in the business combination. + References No definition available. + Details
Name: | usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder
Namespace Prefix: | usph_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of net tangible asset acquired at the acquisition date. + References No definition available. + Details
Name: | usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset
Namespace Prefix: | usph_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Right to require percentage of voting equity interests on the third anniversary of the Metro transaction closing. + References No definition available. + Details
Name: | usph_BusinessAcquisitionRightToRequirePercentageOfVotingInterests
Namespace Prefix: | usph_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Useful life of acquired finite-lived intangible assets in business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife
Namespace Prefix: | usph_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition This element represents the fair value of the redeemable noncontrolling interest in the acquiree at the acquisition date. + References No definition available. + Details
Name: | usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests
Namespace Prefix: | usph_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of non-competition agreements recognized as of the acquisition date. + References No definition available. + Details
Name: | usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements
Namespace Prefix: | usph_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of referral relationships at the acquisition date. + References No definition available. + Details
Name: | usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships
Namespace Prefix: | usph_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of tradename recognized as of the acquisition date. + References No definition available. + Details
Name: | usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename
Namespace Prefix: | usph_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- References No definition available. + Details
Name: | usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract
Namespace Prefix: | usph_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Payments to acquire businesses total consideration. + References No definition available. + Details
Name: | usph_PaymentsToAcquireBusinessesConsideration
Namespace Prefix: | usph_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=usph_MSOMetroLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=usph_DirectorAndOtherOwnersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=usph_IndustrialInjuryPreventionServicesBusinessMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=usph_BriotixHealthLimitedPartnershipMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=usph_PhysicalTherapyOperationsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |